Drug Trial News

RSS

Tight diabetes control does not impact cognitive ability in type 1 diabetes

A study led by researchers at Joslin Diabetes Center provides good news for patients with type 1 diabetes who want to maintain tight blood glucose control and thus significantly reduce their risk of developing the devastating complications of the disease, heart disease, kidney failure, eye disease and blindness and nerve damage.

4 May 2007

Study of damaged gene gives insight into causes of mental illness

Scientists have pinpointed how different types of damage in types of damage to the same gene can cause some people to suffer from schizophrenia while others have major depression.

4 May 2007

Botox decreases pain and intensity of spasticity following a stroke

Final results from a multi-center study shows that repeated treatments of botulinum toxin type A (BoNTA or Botox?) over one year is well tolerated and results in a significant decrease in spasticity, pain frequency and average pain intensity in upper limbs following stroke, according to research from a neurologist at Wake Forest University Baptist Medical Center.

4 May 2007

Tens of thousands of Americans die each year from secondhand tobacco smoke

While the health risks associated with indoor secondhand smoke are well documented, little research has been done on exposure to toxic tobacco fumes outdoors.

4 May 2007

People with a sibling who have had a stroke are almost twice as likely to suffer a stroke themselves

People with a brother or sister who have had a stroke are almost twice as likely as the average American to suffer a stroke themselves, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Study shows effectiveness of Peramivir in mouse model of H5N1 virus infection

BioCryst Pharmaceuticals has announced that investigators at St. Jude Children's Research Hospital, Memphis, TN, reported favorable results evaluating peramivir treatment in an animal model of influenza using a highly virulent strain of H5N1 virus (an avian influenza strain that had caused fatal human infection in Viet Nam).

4 May 2007

Smoking and Crohn's disease

A new study in The American Journal of Gastroenterology suggests that smoking may determine which part of the intestinal tract is attacked in those who suffer from Crohn's disease.

4 May 2007

Simple spit test designed to detect pre-eclampsia in the early stages

The test, which is designed to be used at home, will allow mums-to-be to check for themselves whether they are at risk of the condition, which can be symptomless in the early stages but kills 1000 babies in the UK every year.

4 May 2007

Phase III data on Safinamide in Parkinson's disease

Merck Serono S.A. has announced that Phase III data on safinamide, a new agent in Phase III development for the treatment of Parkinson's disease symptoms, were presented by Professor Fabrizio Stocchi at the American Academy of Neurology 59th Annual Meeting in Boston, Massachusetts, USA.

4 May 2007

Negative pressure wound therapy for pediatric patients

Negative pressure wound therapy is a new innovation in treating severe and complex wounds in children that decreases the need for frequent and stressful dressing changes.

4 May 2007

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

LigoCyte Pharmaceuticals has presented preclinical data showing that immunization with their influenza virus-like particles (VLPs) induced heterosubtypic protection in a virus challenge study.

4 May 2007

HCV patients survival after liver transplantation is not improving

For liver transplant recipients without hepatitis C (HCV), survival has improved over time.

4 May 2007

Mesoblast receives FDA clearance for heart attack stem cell trial

Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.

4 May 2007

Nutritional benefits of egg consumption

Nine studies presented at the Experimental Biology 2007 meeting support the growing body of research on the nutritional benefits of egg consumption, including its promotion of weight loss and its role in providing choline, an essential nutrient often lacking in the diet that promotes brain and memory development and function.

4 May 2007

Binge drinking decreases brain volume

Drinking heavy amounts of alcohol over a long period of time may decrease brain volume, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Amateur boxing and brain damage

Blows to the head in amateur boxing appear to cause brain damage, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 , May 5, 2007.

4 May 2007

Statins reduce risk of stroke and heart attack

People whose cholesterol improved after one month on cholesterol-lowering drugs called statins reduced their risk of stroke and heart attack, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 , May 5, 2007.

4 May 2007